Sarepta Therapeutics (SRPT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 413,464 | 396,781 | 331,817 | 261,238 | 253,500 |
| Cost of Goods | 50,559 | 44,176 | 37,026 | 34,124 | 35,017 |
| Gross Profit | 362,905 | 352,605 | 294,791 | 227,114 | 218,483 |
| Operating Expenses | 328,559 | 328,156 | 315,659 | 360,757 | 356,588 |
| Operating Income | 34,905 | 24,625 | -20,842 | -133,519 | -138,088 |
| Other Income | 6,543 | 15,746 | -12,332 | 118,934 | -374,622 |
| Pre-tax Income | 41,448 | 40,371 | -33,174 | -14,585 | -512,710 |
| Income Tax | 5,329 | -5,284 | 7,763 | 9,355 | 4,045 |
| Net Income Continuous | 36,119 | 45,655 | -40,937 | -23,940 | -516,755 |
| Net Income | $36,119 | $45,655 | $-40,937 | $-23,940 | $-516,755 |
| EPS Basic Total Ops | 0.38 | 0.79 | -0.46 | -0.27 | -5.86 |
| EPS Basic Continuous Ops | 0.38 | 0.79 | -0.46 | -0.27 | -5.86 |
| EPS Diluted Total Ops | 0.37 | 0.79 | -0.46 | -0.27 | -5.86 |
| EPS Diluted Continuous Ops | 0.36 | 0.79 | -0.46 | -0.27 | -5.86 |
| EPS Diluted Before Non-Recurring Items | N/A | 0.47 | -0.46 | -0.27 | -1.44 |
| EBITDA(a) | $31,248 | $22,668 | $-22,516 | $-134,321 | $-135,434 |